Covidien, Agency Urge Justices To Skip AIA Process Case
By Kevin Penton ( December 15, 2016, 7:20 PM EST) -- Health products company Covidien and the U.S. Patent and Trademark Office have challenged a Johnson & Johnson unit's assertion that the America Invents Act bars the Patent Trial and Appeal Board from using the same panel to both open and decide a case, telling the U.S. Supreme Court that the 2011 law gives the agency's director broad discretion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.